LYON, FRANCE--(Marketwired - Mar 10, 2016) - Flamel Technologies (NASDAQ: FLML) today announced its financial results for the fourth quarter and full year of 2015.
Fourth Quarter Highlights Include:
Total revenue for fourth quarter 2015 was $43.4 million, compared to $3.0 million during the same period last year. GAAP net income for the fourth quarter was $76.1 million, or $1.75 per diluted share, compared to a GAAP net loss of ($27.1) million, or ($0.69) per diluted share, for the same period last year.
Adjusted net income* for the fourth quarter was $13.9 million, or $0.32 per diluted share, compared to an adjusted net loss* of ($9.7) million, or ($0.25) per diluted share, during the same period last year.
Cash and marketable securities at December 31, 2015 were $144.8 million, compared to $128.4 million at September 30, 2015 and $92.8 million at December 31, 2014.
Acquisition of FSC Pediatrics in February 2016 provides four new commercial stage products and established commercial infrastructure.
Fourth Quarter Highlights Include:
Total revenue for fourth quarter 2015 was $43.4 million, compared to $3.0 million during the same period last year. GAAP net income for the fourth quarter was $76.1 million, or $1.75 per diluted share, compared to a GAAP net loss of ($27.1) million, or ($0.69) per diluted share, for the same period last year.
Adjusted net income* for the fourth quarter was $13.9 million, or $0.32 per diluted share, compared to an adjusted net loss* of ($9.7) million, or ($0.25) per diluted share, during the same period last year.
Cash and marketable securities at December 31, 2015 were $144.8 million, compared to $128.4 million at September 30, 2015 and $92.8 million at December 31, 2014.
Acquisition of FSC Pediatrics in February 2016 provides four new commercial stage products and established commercial infrastructure.
